Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory May 19, 2026 19 May 2026 NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB The shareholders in Acarix AB (publ) corp. reg. no 559009-0667 (the “Company”) are hereby convened to an annual general mee... Continue reading
Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish May 19, 2026 19 May 2026 KALLELSE TILL ÅRSSTÄMMA I Acarix AB Aktieägarna i Acarix AB, org.nr 559009-0667 (”Bolaget”) kallas härmed till årsstämma onsdagen den 17 j... Continue reading
English, Interim, IR, Listing Regulation, News, Q1, Regulatory, Report May 18, 2026 18 May 2026 Acarix Publishes Interim Report, January – March 2026 Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the first quarte... Continue reading
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory May 4, 2026 04 May 2026 Acarix Changes Publication Date for Q1 2026 Interim Report Acarix (ticker: Acarix) hereby announces that the company is postponing the release of its interim report for the first quarter of 2026... Continue reading
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish May 4, 2026 04 May 2026 Acarix ändrar datum för publicering av delårsrapport för Q1 2026 Acarix (ticker: Acarix) meddelar härmed att bolaget flyttar fram publiceringstidpunkten för delårsrapporten för de... Continue reading
Annual, IR, Listing Regulation, News, Regulatory, Report, Swedish April 15, 2026 15 Apr 2026 Acarix AB’s Årsredovisning 2025 Acarix, ledande inom AI och avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2025 finns t... Continue reading
Annual, English, IR, Listing Regulation, News, Regulatory, Report April 15, 2026 15 Apr 2026 Acarix AB’s Annual Report 2025 Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2025 is avail... Continue reading
Corporate Information, English, IR, News, Other Corporate Information April 7, 2026 07 Apr 2026 ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM’S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS Findings demonstrate high NPV, care time savings of up to 40 hours, and cost reductions exceeding $100,000 per inpatient case, reinforc... Continue reading
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend February 12, 2026 12 Feb 2026 Acarix Publishes Year-End Report 2025 Malmö, Sweden – Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end finan... Continue reading
Corporate Information, English, IR, News, Other Corporate Information February 11, 2026 11 Feb 2026 Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System Malmö, Sweden – Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics... Continue reading
Corporate Information, English, IR, News, Other Corporate Information February 4, 2026 04 Feb 2026 Acarix Receives EU MDR Certification for the CADScor®System Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor Sys... Continue reading
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish December 8, 2025 08 Dec 2025 ACARIX GENOMFÖR EN RIKTAD EMISSION OM CIRKA 33,4 MSEK Styrelsen i Acarix AB (publ) (”Acarix” eller ”Bolaget”) har idag beslutat om att genomföra en riktad nyemi... Continue reading